RIGL
Rigel Pharmaceuticals Inc. (New)Data: 2026-10-01
Quick Stats
Oct 01, 202645.8
AI Score
HOLD0.95
Volume Ratio
Nov 03, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
RIGL Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
RIGL Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
RIGL Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RIGL Daily Out of Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RIGL Daily In the Money Options - Sort by Max open Interest (near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RIGL Most Active Options by Volume(near term)
2nd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RIGL Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RIGL Stock Summary
Last updated Oct 01, 2026
RIGL is currently trading at $46.97, positioned above its 200-day moving average of $36.52, indicating a long-term uptrend. The stock has a 52-week range of $24.95 to $52.24.
Technical Analysis: The 50-day moving average stands at $44.27, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 51.51, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.047, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RIGL at 45.8/100 with a HOLD recommendation.
RIGL (Rigel Pharmaceuticals Inc. (New)) Indicators
Last updated Oct 01, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 51.51 |
| CMF (20) | 0.047 |
| ROC (10) | 2.443 |
| ADX (14) | 25.907 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.905 |
| AROONOSC (14) | 71.429 |
| WILLAMS %R (14) | -46.115 |
| MFI (14) | 56.597 |
RIGL Candlestick Patterns
No validated candlestick patterns fired for RIGL in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Rigel Pharmaceuticals Inc. (New) is above both the 50 Day and 200 Day SMA which is considered Bullish.
RIGL Moving Averages Analysis
Rigel Pharmaceuticals Inc. (New) has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 01, 2026
Rigel Pharmaceuticals Inc. (New) has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 01, 2026
RIGL (Rigel Pharmaceuticals Inc. (New)) Simple Moving Averages
Moving Averages are last updated Oct 01, 2026
| Days | MA |
|---|---|
| 10 | 48.01 |
| 20 | 47.32 |
| 30 | 47.08 |
| 50 | 44.27 |
| 100 | 39.38 |
| 200 | 36.52 |
RIGL Fundamental Analysis
| P/E (Forward) | 9.2851 |
| P/E (Trailing) | 2.8936 |
| Market Cap ($) | 899.4 million |
| Earnings/Share ($) | 16.64 |
| Net Profit Margin (%) | 1.163 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 3.5427 |
| EPS Estimate Next Year ($) | 4.9392 |
| WallStreet Target Price ($) | 63.00 |
| Most Recent Quarter |
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.